Healthcare provider profile · identity verified

Mai T Le, MD

Internal Medicine · STOCKTON, CA · NPI 1497878607

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	413	156
Losartan Potassium	Losartan Potassium	231	82
Amlodipine Besylate	Amlodipine Besylate	212	86
Lisinopril	Lisinopril	183	71
Levothyroxine Sodium	Levothyroxine Sodium	167	63
Fluticasone Propionate	Fluticasone Propionate	112	56
Metformin Hcl Er	Metformin Hcl	108	41
Gabapentin	Gabapentin	97	39
Alendronate Sodium	Alendronate Sodium	95	40
Jardiance	Empagliflozin	93	36
Albuterol Sulfate Hfa	Albuterol Sulfate	89	36
Omeprazole	Omeprazole	87	37
Hydrochlorothiazide	Hydrochlorothiazide	82	33
Metformin Hcl	Metformin Hcl	78	31
Metoprolol Succinate	Metoprolol Succinate	78	31
Breyna	Budesonide/Formoterol Fumarate	76	38
Furosemide	Furosemide	75	34
Glipizide	Glipizide	70	28
Metoprolol Tartrate	Metoprolol Tartrate	66	28
Famotidine	Famotidine	63	24
Rosuvastatin Calcium	Rosuvastatin Calcium	59	24
Tamsulosin Hcl	Tamsulosin Hcl	59	22
Allopurinol	Allopurinol	56	26
Pantoprazole Sodium	Pantoprazole Sodium	56	18
Simvastatin	Simvastatin	56	21
Atenolol	Atenolol	53	22
Carvedilol	Carvedilol	53	16
Tizanidine Hcl	Tizanidine Hcl	50	34
Ozempic	Semaglutide	49	17
Potassium Chloride	Potassium Chloride	49	18
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	47	17
Azithromycin	Azithromycin	45	43
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	44	15
Montelukast Sodium	Montelukast Sodium	43	25
Trazodone Hcl	Trazodone Hcl	43	11
Doxycycline Monohydrate	Doxycycline Monohydrate	42	31
Ibuprofen	Ibuprofen	42	19
Hydralazine Hcl	Hydralazine Hcl	41	18
Triamcinolone Acetonide	Triamcinolone Acetonide	37	26
Baclofen	Baclofen	36	11
Nystatin	Nystatin	35	15
Alvesco	Ciclesonide	32	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	28	25
Cephalexin	Cephalexin	28	28
Lovastatin	Lovastatin	28	suppressed
Mirtazapine	Mirtazapine	27	13
Fluocinonide	Fluocinonide	26	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	25	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	24	16
Zolpidem Tartrate	Zolpidem Tartrate	23	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	22	14
Sertraline Hcl	Sertraline Hcl	22	12
Clopidogrel	Clopidogrel Bisulfate	21	suppressed
Ciclopirox	Ciclopirox	20	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	20	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	19	19
Hydrocortisone	Hydrocortisone	19	11
Sumatriptan Succinate	Sumatriptan Succinate	19	suppressed
Glipizide Er	Glipizide	18	suppressed
Pravastatin Sodium	Pravastatin Sodium	18	suppressed
Colchicine	Colchicine	17	suppressed
Propranolol Hcl Er	Propranolol Hcl	17	suppressed
Humulin N	Insulin Nph Human Isophane	16	suppressed
Mupirocin	Mupirocin	16	16
Citalopram Hbr	Citalopram Hydrobromide	15	suppressed
Ofloxacin	Ofloxacin	14	11
Ondansetron Odt	Ondansetron	14	suppressed
Prednisone	Prednisone	13	13
Sucralfate	Sucralfate	13	suppressed
Temazepam	Temazepam	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Alclometasone Dipropionate	Alclometasone Dipropionate	12	suppressed
Amoxicillin	Amoxicillin	12	11
Clonidine Hcl	Clonidine Hcl	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Brilinta	Ticagrelor	11	suppressed
Cefadroxil	Cefadroxil	11	11
Duloxetine Hcl	Duloxetine Hcl	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Naproxen	Naproxen	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed
Spironolactone	Spironolactone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error